News

AstraZeneca and MedImmune announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for moxetumomab pasudotox, an investigational…
Read More...

Compugen Ltd. announced it entered into an exclusive license agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to enable the development of…
Read More...

Q-State Biosciences announced that the company has entered into a strategic collaboration with Vertex Pharmaceuticals Incorporated to discover drugs using Q-State’s novel Optopatch…
Read More...

Puma Biotechnology and Pint Pharma International have entered into an agreement for Pint Pharma to commercialize NERLYNX (neratinib) in Argentina, Brazil, Chile, Colombia, Mexico and…
Read More...

MRI analysis of patients who received intradiscal injections of human dermal fibroblasts (HDFs) shows significant improvement in disc height after six months. This is the latest…
Read More...

PharmaCyte Biotech, Inc. announced that vials of cells from PharmaCyte’s Master Cell Bank (MCB) have been shipped by Eurofins Lancaster Laboratories (Eurofins) to Austrianova’s…
Read More...

Dr. Reddy’s Laboratories Ltd and its subsidiary, Promius Pharma, LLC announced the filing of New Drug Application (NDA) for its migraine candidate DFN-02 with the U.S. Food and Drug…
Read More...

Synlogic announced that the first patient was dosed in its Phase 1b/2a clinical trial of SYNB1020. SYNB1020 is a Synthetic Biotic medicine being developed for the treatment of…
Read More...

PharmAbcine announced that U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its leading clinical compound TTAC-0001 for “treatment of Glioblastoma…
Read More...

Martin Pharmaceuticals, a clinical stage pharmaceutical company focused on repurposing already-approved drugs to offer life-changing advances to patients afflicted with rare (orphan)…
Read More...

Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys’…
Read More...

Pfizer Inc. announced that the Tafamidis Phase 3 Transthyretin Cardiomyopathy (ATTR-ACT) study evaluating tafamidis for the treatment of transthyretin cardiomyopathy met its primary…
Read More...

Abide Therapeutics announced that it has granted Celgene an exclusive worldwide license for ABX-1772, a preclinical drug candidate discovered by Abide. In connection with the license,…
Read More...

Clinipace Worldwide has announced the appointment of Ian Fraser as senior vice president of operations for the European Union and Middle East (EUME). In his new role, Fraser will lead…
Read More...

Breckenridge Pharmaceutical announced that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Entecavir tablets USP, 0.5mg and…
Read More...

Acerus Pharmaceuticals Corporation announced that it has entered into an exclusive distributor and license agreement with Metuchen Pharmaceuticals, a privately-held specialty…
Read More...

FORMA Therapeutics announced the appointment of Frances Duffy-Warren, Ph.D., to the leadership team as Head of Regulatory Affairs. Frances brings more than 30 years of pharmaceutical…
Read More...

Pharmaceutical Product Development, LLC (PPD) has expanded its GMP (good manufacturing practices) analytical laboratory in Middleton, Wisconsin. PPD Laboratories’ new 32,000-square-foot…
Read More...

Eagle Pharmaceuticals announced that the Company’s Eagle Biologics division has been issued a new patent by the United States Patent and Trademark Office (USPTO). Patent number…
Read More...

The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved…
Read More...